Acurx Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
0
Price Target
$12.00
Consensus
Outperform
Upside
455.56%
Analysts
0
Stock Rating
0
Upside
455.56%
Analysts
0
Price Target
$12.00

Acurx Pharmaceuticals Stock Forecast and Price Target

According to esteemed experts, the average price target for Acurx Pharmaceuticals to reach this year is $12.00, with a potential upside of approximately 455.56%. This prediction is based on a high estimate of $12.35 and a low estimate of $10.00.

$12.00

455.56% Upside

Outperform
Outperform

Acurx Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Acurx Pharmaceuticals's Price has grown from $0.00 to $0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach $0.00 – an increase of 100.00%. Over the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Acurx Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

Acurx Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

Acurx Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

Acurx Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

Acurx Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

Acurx Pharmaceuticals's EBIT has decreased by 5.62% In the last year, from $-12.81M to $-12.09M. In the next year, analysts believe that EBIT will reach $-12.81M – an increase of 5.96%. For the next eight years, experts predict that Acurx Pharmaceuticals's EBIT will grow at a rate of 4.00%.

2023 EBIT Forecast
$-12810564.00
2024 EBIT Forecast
$-12585098.07
2025 EBIT Forecast
$-12674452.27
2026 EBIT Forecast
$-12483068.04
2027 EBIT Forecast
$-12592086.83
2028 EBIT Forecast
$-12590407.89
2029 EBIT Forecast
$-12618526.47
2030 EBIT Forecast
$-12573099.77

Acurx Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Acurx Pharmaceuticals's EPS has grown from $-1.12 to $0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach $0.00 – an increase of 100.00%. Over the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00